Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses

Journal of Virology

Volumn 89, Issue 7, 2015, Pages 3763-3775

  Koel, Björn F ^a   Mögling, Ramona ^a,b   Chutinimitkul, Salin ^a   Fraaij, Pieter L ^a,c   Burke, David F ^b   van der Vliet, Stefan ^a   de Wit, Emmie ^a,d   Bestebroer, Theo M ^a   Rimmelzwaan, Guus F ^a   Osterhaus, Albert D M E ^a   Smith, Derek J ^a,b   Fouchier, Ron A M ^a   de Graaf, Miranda ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

2009 H1N1 INFLUENZA; ADAPTIVE IMMUNITY; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SEASONAL INFLUENZA; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; ANTIGENIC VARIATION; BLOOD; FERRET; GENETIC DRIFT; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

INFLUENZA A VIRUS; MUSTELA;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; ANTIGENS, VIRAL; DNA MUTATIONAL ANALYSIS; EPITOPES, B-LYMPHOCYTE; FERRETS; GENETIC DRIFT; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; VIRUS REPLICATION;

EID: 84924811650     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02962-14     Document Type: Article

References (47)

1. Sorrell EM, Schrauwen EJ, Linster M, De Graaf M, Herfst S, Fouchier RA. 2011. Predicting 'airborne' influenza viruses: (trans-) mission impossible?. Curr Opin Virol 1:635-642. http://dx.doi.org/10.1016/j.coviro.2011.07.003.
2. Nakajima K, Desselberger U, Palese P. 1978. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 274:334-339. http://dx.doi.org/10.1038/274334a0.
3. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615. http://dx.doi.org/10.1056/NEJMoa0903810.
4. World Health Organization. February 2014. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. World Health Organization, Geneva, Switzerland. http://www.who.int/influenza/vaccines/virus/recommendations/201402_recommendation.pdf?ua=1.
5. Virelizier JL. 1975. Host defenses against influenza virus: the role of antihemagglutinin antibody. J Immunol 115:434-439.
6. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427. http://dx.doi.org/10.1016/0092-8674(82)90135-0.
7. Gerhard W, Yewdell J, Frankel ME, Webster R. 1981. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290:713-717. http://dx.doi.org/10.1038/290713a0.
8. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378. http://dx.doi.org/10.1038/289373a0.
9. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG. 2007. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81:12911-12917. http://dx.doi.org/10.1128/JVI.01522-07.
10. Kaverin NV, Rudneva IA, Ilyushina NA, Varich NL, Lipatov AS, Smirnov YA, Govorkova EA, Gitelman AK, Lvov DK, Webster RG. 2002. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol 83:2497-2505.
11. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. 2013. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342:976-979. http://dx.doi.org/10.1126/science.1244730.
12. Koel BF, van der Vliet S, Burke DF, Bestebroer TM, Bharoto EE, Yasa IW, Herliana I, Laksono BM, Xu K, Skepner E, Russell CA, Rimmelzwaan GF, Perez DR, Osterhaus AD, Smith DJ, Prajitno TY, Fouchier RA. 2014. Antigenic variation of clade 2.1 H5N1 virus is determined by a few amino acid substitutions immediately adjacent to the receptor binding site. mBio 5(3):e01070-14. http://dx.doi.org/10.1128/mBio.01070-14.
13. de Graaf M, Fouchier RA. 2014. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J 33:823-841. http://dx.doi.org/10.1002/embj.201387442.
14. Rogers GN, Paulson JC. 1983. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127:361-373. http://dx.doi.org/10.1016/0042-6822(83)90150-2.
15. Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, Hongo S. 2004. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 78: 9605-9611. http://dx.doi.org/10.1128/JVI.78.18.9605-9611.2004.
16. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, Wilson IA, Wiley DC. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci USA 81:1779-1783. http://dx.doi.org/10.1073/pnas.81.6.1779.
17. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ. 2009. Antigenic and genetic characteristics of swineorigin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201. http://dx.doi.org/10.1126/science.1176225.
18. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125. http://dx.doi.org/10.1038/nature08182.
19. de Jong JC, Smith DJ, Lapedes AS, Donatelli I, Campitelli L, Barigazzi G, Van Reeth K, Jones TC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2007. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol 81:4315-4322. http://dx.doi.org/10.1128/JVI.02458-06.
20. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357-360. http://dx.doi.org/10.1126/science.1186430.
21. Yang H, Carney P, Stevens J. 2010. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr 2:RRN1152. http://dx.doi.org/10.1371/currents.RRN1152.
22. Centers for Disease Control and Prevention. 2009. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.MMWRMorb Mortal Wkly Rep 58:521-524.
23. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA. 2009. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325:481-483. http://dx.doi.org/10.1126/science.1177127.
24. Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, van Riel D, Schrauwen EJ, Bestebroer TM, Koel B, Burke DF, Sutherland-Cash KH, Whittleston CS, Russell CA, Wales DJ, Smith DJ, Jonges M, Meijer A, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Garcia-Sastre A, Perez DR, Fouchier RA. 2010. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 84:11802-11813. http://dx.doi.org/10.1128/JVI.01136-10.
25. de Wit E, Spronken MI, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res 103:155-161. http://dx.doi.org/10.1016/j.virusres.2004.02.028.
26. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97:6108-6113. http://dx.doi.org/10.1073/pnas.100133697.
27. Hirst GK. 1943. Studies of antigenic differences among strains of influenza a by means of red cell agglutination. J Exp Med 78:407-423. http://dx.doi.org/10.1084/jem.78.5.407.
28. Matrosovich M, Matrosovich T, Garten W, Klenk HD. 2006. New low-viscosity overlay medium for viral plaque assays. Virol J 3:63. http://dx.doi.org/10.1186/1743-422X-3-63.
29. Nobusawa E, Ishihara H, Morishita T, Sato K, Nakajima K. 2000. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 278:587-596. http://dx.doi.org/10.1006/viro.2000.0679.
30. de Vries RP, de Vries E, Martinez-Romero C, McBride R, van Kuppeveld FJ, Rottier PJ, Garcia-Sastre A, Paulson JC, de Haan CA. 2013. Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol 87:13868-13877. http://dx.doi.org/10.1128/JVI.01955-13.
31. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, Wilson IA. 2006. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355:1143-1155. http://dx.doi.org/10.1016/j.jmb.2005.11.002.
32. Chutinimitkul S, van Riel D, Munster VJ, van den Brand JM, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA, de Wit E. 2010. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol 84:6825-6833. http://dx.doi.org/10.1128/JVI.02737-09.
33. Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. 2013. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med 5:198ra107. http://dx.doi.org/10.1126/scitranslmed.3006637.
34. Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NM, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WE, Le QM, Nguyen TH, Wertheim HF, Hurt AC, Osterhaus AD, Barr IG, Fouchier RA, Horby PW, Smith DJ. 2014. Antibody landscapes after influenza virus infection or vaccination. Science 346:996-1000. http://dx.doi.org/10.1126/science.1256427.
35. Chen Z, Wang W, Zhou H, Suguitan AL, Jr, Shambaugh C, Kim L, Zhao J, Kemble G, Jin H. 2010. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in em-bryonated chicken eggs. J Virol 84:44-51. http://dx.doi.org/10.1128/JVI.02106-09.
36. O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, Li GM, McCausland M, Zheng NY, Yewdell JW, Ahmed R, Wilson PC, Subbarao K. 2012. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. mBio 3(3):e00120-12. http://dx.doi.org/10.1128/mBio.00120-12.
37. Rudneva I, Ignatieva A, Timofeeva T, Shilov A, Kushch A, Masalova O, Klimova R, Bovin N, Mochalova L, Kaverin N. 2012. Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin. Virus Res 166:61-67. http://dx.doi.org/10.1016/j.virusres.2012.03.003.
38. Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, Petrie S, McCaw JM, McVernon J, Hurt AC, Kelso A, Mosse J, Barr IG, Laurie KL. 2013. Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in a ferret model. PLoS Pathog 9:e1003354. http://dx.doi.org/10.1371/journal.ppat.1003354.
39. Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, Hensley SE. 2013. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med 210:1493-1500. http://dx.doi.org/10.1084/jem.20130212.
40. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bosecke P, Wharton SA, Skehel JJ, Knossow M. 1995. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 376:92-94. http://dx.doi.org/10.1038/376092a0.
41. Soundararajan V, Tharakaraman K, Raman R, Raguram S, Shriver Z, Sasisekharan V, Sasisekharan R. 2009. Extrapolating from sequence-the 2009 H1N1 'swine' influenza virus. Nat Biotechnol 27:510-513. http://dx.doi.org/10.1038/nbt0609-510.
42. Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, Reyes-Teran G, Ross TM, Wilson PC, Ahmed R, Bloom JD, Hensley SE. 2014. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc Natl Acad Sci USA 111:15798-15803. http://dx.doi.org/10.1073/pnas.1409171111.
43. Adinolfi M, Lessof MH. 1972. Development of humoral and cellular immunity in man. J Med Genet 9:86-91. http://dx.doi.org/10.1136/jmg.9.1.86.
44. Bodewes R, de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, Koopmans M, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2011. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 18:469-476. http://dx.doi.org/10.1128/CVI.00396-10.
45. Carter DM, Bloom CE, Nascimento EJ, Marques ET, Craigo JK, Cherry JL, Lipman DJ, Ross TM. 2013. Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J Virol 87:1400-1410. http://dx.doi.org/10.1128/JVI.02257-12.
46. European Commission. November 1986. EU directive on animal testing. Directive 86/609/EEC. European Commission, Brussels, Belgium. http://ec.europa.eu/food/fs/aw/aw_legislation/scientific/86-609-eec_en.pdf.
47. Ministry of Education, Culture and Science. January 1997. Experiments on Animals Act. Ministerie van Volksgezondheid en Milieuhygiëne, The Hague, The Netherlands. http://wetten.overheid.nl/BWBR0003081.